Neuropsychiatric adverse effects following switch to vanzacaftor–tezacaftor–deutivacaftor in adults with cystic fibrosis: early experience from a regional centre

Journal of Cystic Fibrosis · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles